1052364

Alexander Perl, MD — FEI 3014355324

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 18, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance